Delivery Order SPE2DB24D1205-SPE2DB25FCVKV

Award Date 3/31/25
Potential Completion Date 4/1/25
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Plaquenil 200 mg tablets in 100-count packages. The contract has a firm fixed price and a ceiling value of $33,529.91. It was awarded on January 15, 2025, with an ultimate completion date of January 16, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,026.35, is for the delivery of Plaquenil 200 mg tablets over the period ending November 12, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation indicated. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award is for the delivery of Plaquenil 200 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $77,941.18 and runs through June 5, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and expiring in...
This federal contract award is a delivery order (SPE2DB20D2104|SPE2DB25FMJKJ) from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,899.37, is for the supply of Plaquenil 200 mg tablets to support federal healthcare programs. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,839.27, is for the delivery of 4560864318 units of Plaquenil 200 mg tablets. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of May 9, 2023. This award is not a set-aside contract. Amerisourcebergen Drug Corp is the...
The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at three thousand seven hundred eighty-five dollars and eighty-four cents ($3,785.84) to Amerisourcebergen Drug Corporation for the provision of two hundred (200) tablets of Plaquenil, a malaria drug. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with work scheduled to be completed by July 20, 2023 under the contract start date of July 19, 2023. No...
This federal contract award, with the ID SPE2DB20D3103|SPE2DB24FL8W1, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,563,080 units of hydroxychloroquine 200 mg tablets, with a ceiling value of $3,572.70 and a completion date of December 13, 2023. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,243.72, is for the delivery of 4567088287 - CHLOROQUINE PH 500 MG TABLET 25S. This is a firm fixed-price delivery order contract with a completion date of January 30, 2025. The contract is not designated under any set-aside program. Amerisourcebergen holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of PRIMAQUINE 26.3 MG TABLET 100S. The award has a ceiling value of $1,514.06 and is a firm fixed-price delivery order contract, with an ultimate completion date of May 28, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of pharmaceutical products and medical supplies to the U.S. government. The contract, awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, has a ceiling value of $25,656.54 and a completion date of September 3, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999 through December 2025. This IDC...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB25FCVKV
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) to provide PLAQUENIL 200 MG TABLET 100S. The award has a ceiling value of $2,191.75 and is a Firm Fixed Price Delivery Order contract that runs through April 1, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 6/30/25, 10:46 AM